Search research articles
Contact Us
Filters
Showing results (101-110 of 140) with videos related to
Page
of 14
Sort By:
Clinical Case Reports
|
November 30, 2022
Tophaceous gout of the nose in a male <i>FMR1</i> premutation carrier
Si Jie Tang, Shanthi Giri, Nima Pahlavan, et al.
Neuroscience and Biobehavioral Reviews
|
November 14, 2006
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X
Danuta Z Loesch, Quang M Bui, Cheryl Dissanayake, et al.
Journal of Neurodevelopmental Disorders
|
June 30, 2010
Aging in fragile X syndrome
Agustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Pediatrics
|
January 2, 2009
Advances in the treatment of fragile X syndrome
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
April 11, 2013
A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, et al.
Brain Sciences
|
December 19, 2018
Best Practices in Fragile X Syndrome Treatment Development
Craig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders
|
August 3, 2017
A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
Andrew Ligsay, Anke Van Dijck, Danh V Nguyen, et al.
Brain Communications
|
January 9, 2026
Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inference
Douglas Ezra Morrison, Matthew Dominic Ponzini, Ellery R Santos, et al.
Neurology
|
February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disability
Rebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Movement Disorders Clinical Practice
|
May 19, 2022
Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression
Yingratana A McLennan, Matthew W Mosconi, Forrest J McKenzie, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 140) with videos related to
Sort By:
Page
of 14
Clinical Case Reports
|
November 30, 2022
Tophaceous gout of the nose in a male <i>FMR1</i> premutation carrier
Si Jie Tang, Shanthi Giri, Nima Pahlavan, et al.
Neuroscience and Biobehavioral Reviews
|
November 14, 2006
Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X
Danuta Z Loesch, Quang M Bui, Cheryl Dissanayake, et al.
Journal of Neurodevelopmental Disorders
|
June 30, 2010
Aging in fragile X syndrome
Agustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Pediatrics
|
January 2, 2009
Advances in the treatment of fragile X syndrome
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
April 11, 2013
A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, et al.
Brain Sciences
|
December 19, 2018
Best Practices in Fragile X Syndrome Treatment Development
Craig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders
|
August 3, 2017
A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
Andrew Ligsay, Anke Van Dijck, Danh V Nguyen, et al.
Brain Communications
|
January 9, 2026
Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inference
Douglas Ezra Morrison, Matthew Dominic Ponzini, Ellery R Santos, et al.
Neurology
|
February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disability
Rebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Movement Disorders Clinical Practice
|
May 19, 2022
Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression
Yingratana A McLennan, Matthew W Mosconi, Forrest J McKenzie, et al.
Page
of 14